跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATACAND 32 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ATACAND 32 MG COMPRIMIDOS
Approved
STANDARD
ATACAND 32 MG COMPRIMIDOS
Cheplapharm Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 19, 2023
Approval ID
f8f23a14b1fbf44d
Company
Cheplapharm Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
f8f23a14b1fbf44d
Drug Cima Aemps Name
ATACAND 32 MG COMPRIMIDOS
Register Number
35812-16-04-2021IP
Holder Company Name
Cheplapharm Arzneimittel Gmbh
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/cheplapharm-arzneimittel-gmbh
Authorization Date
2023-10-19
Dosage Form
COMPRIMIDO
Dose
32 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Cheplapharm Arzneimittel Gmbh
Company Detail Path
/organization/cheplapharm-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
Cheplapharm Arzneimittel Gmbh
Country Name
Norway
City Name
utlandet,country_no
Address
Ziegelhof 24DE-17489 GREIFSW
Website
http://www.cheplapharm.com
Active Ingredients
CANDESARTAN CILEXETILO
32 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 19, 2023
Approval ID
f8f23a14b1fbf44d
Type
Standard
Back to CIMA-AEMPS Approvals